US FDA approves Mallinckrodt’s Terlivaz for injection to treat Hepatorenal Syndrome EP News Bureau Sep 16, 2022 Terlivaz is the first and only FDA-approved treatment for adults with HRS involving rapid reduction in kidney function
US FDA denies approval to Mallinckrodt for Terlipressin to treat Hepatorenal Syndrome Type 1 EP News Bureau Sep 15, 2020 The Complete Response Letter stated that, based on the available data, the agency cannot approve the terlipressin NDA in its…
